Patent · US Expired

Peptides

US6130204A · kind A · utility

7Cited by
20References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 6, 1998
Grant dateOct 10, 2000
Priority date
Expiry dateApr 6, 2018

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10S930/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Oligopeptides which comprise amino acid sequences that are recognized and proteolytically cleaved by free prostate specific antigen (PSA) are described. Also described are assays which comprise such oligopeptides useful for determining free PSA protease activity in vitro and in vivo. Therapeutic agents which comprise conjugates of such oligopeptides and known cytotoxic agents are also described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.